Q: I realize you have better prospects than these but I am wondering if you can make a buy case for longer term holds. Could you also provide some of your current small cap favorites . Thanx Robbie
Q: I like the concept of this company going forward but am somewhat concerned about the lack of proven technology. Does 5i have a view on this company?
Q: I own these three US traded companies. my question is are they all bankrupt and should I be gifting them to my online brokers TD, to clean up my portfolio. mlkkf,rbeif,guesf
Q: I would appreciate your comments on Flyht Aerospace Solutions (FLY) Second Quarter Update released today. The stock is up over 5% on this news release but down 50% on a year to date basis. Is this a buying opportunity at today's price? What will it take for Flyht stock to move significantly higher? Thanks
Q: Peter and His Wonder Team
I know you do not cover this USA stock. It was a Top Pick on BNN recently. Today it crashed over 60%. Anything on the wire? Your thoughts please.
Q: Hi, thoughts on ADW at current price? Why is it being pushed down and looks technically negative at this point. With DWS recent acquisition and new exposure nationally, I am liking the risk / reward with DWS right now. Would you own both?
Q: Do you have a view on this company? Many shareholders are frustrated with the lack of information coming from the corporate office. It appears that institutional investors are not buying their story and retail investors are leaving. Your thoughts please.
Q: In my last question you indicated that mittleman has 0.05% of the shares. They actually own 16-17% ie 27M shares and just joined the board as an activist, changed the CEO etc. This play is very reminiscent of Buffett’s Blue Chip Stamps. So I’ll ask again, what’s with the buying and selling of shares. They have made some big buys in the past month, but they appear to be selling some, or is this just administrative adjustment of shares in their fund?
Q: What can you tell me about Revive Therapeutics. I know it's risky and you likely won't recommend it, but any information would be helpful. The stock has jumped on news of receiving orphan drug status for one of their programs. Is this overly significant? I know it creates excitement, but ultimately how does it add to the actual value of the stock?
Q: Could I have your take on the - Stonegate Capital Partners Updates Coverage published today. As a summary the report focuses on 7 points regarding the company, specifically the last 3 points IRR, inside ownership and valuation... do you agree with the points they make here? Then generally, do you view this report as useful investment information or do you see it more as an advertisement?